Immunogenicity of Simulated PCECV Postexposure Booster Doses 1, 3, and 5 Years after 2-Dose and 3-Dose Primary Rabies Vaccination in Schoolchildren
Figure 2
Immune response after two simulated post-exposure intradermal 0.1 mL booster doses of PCECV on days 0 and 3, administered one (a), three (b), or five years (c) after completion of a primary vaccination series. ⚫: 2 ID doses; ■: 3 ID doses; error bars represent 95% confidence intervals : RVNA concentrations regarded as adequate for protection. (0.5 IU/mL).
